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ABSTRACT Territorial innovation models and policy practices traditionally tend to associate the
emergence, resurgence and growth of start-ups with the development of local industries, either as
industrial pioneers or as innovative spinoffs embedded in a regional production system. This
approach is in line with a “life cycle” pattern of innovation and of industrialization marked by
sequential waves of growth and decline, by technological renewal and by sectorial transitions. In
a knowledge and financial economy characterized by combinatorial knowledge dynamics, by even
shorter project-based innovations and by global financial and production networks, this approach
is called into question. Through the case of Swiss medical technologies (Medtech), this paper
highlights how local medtech start-ups’ evolution is shaped, from its early phase on, by the
corporate venture strategies of multinational companies. While the economic potential of start-
ups was traditionally perceived in a longer run, they seem to be more often “born to be sold”
today. New research avenues and policy issues are finally derived from this particular case to
address territorial innovation and competitiveness in the future.
Introduction
In Schumpeterian ontology, entrepreneurs personalize economic change by their capacity
to create and exploit new production or market opportunities. Beyond an individual action,
entrepreneurship is also perceived as a collective innovation process embedded in territor-
ialized institutions, actor relations and evolutionary pathways. Widely investigated since
the 1980s, the Silicon Valley model has played a large part in carrying out and legitimizing
this ontology through idealized visions of it. At the same time, it has become a reference of
territorial competitiveness advocated by the current policy discourses and practices.
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Nowadays, the familiar figures of William Hewlett, David Packard, Steve Jobs, Bill
Gates, Larry Page or Sergey Brin typify the iconic image of entrepreneurs developing
a new idea, prototyping a new product and starting a new business in their “garage”
(Audia & Rider, 2005). Start-ups symbolize contemporary entrepreneurship at the cross-
roads of science and industry, embedded in regional networks of firms, research and edu-
cation bodies and capital ventures (Florida & Kenney, 1988). They are analysed at the
core of nascent industries forging the resilience of a flexible regional production
system exporting innovative and competitive products to distant markets (Saxenian,
1990, 1991).
The aforementioned entrepreneurial projects, the image of “garage” entrepreneurs and
start-ups, reflect a “life cycle” pattern of innovation and of industrialization marked by
sequential waves of growth and decline, by technological renewal and by sectoral tran-
sitions. Often associated with the success stories of Hewlett-Packard, Apple, Microsoft
or Google, start-ups are commonly viewed as the potential inception of a new industrial
trajectory which is expected to grow, create jobs and disseminate innovation locally.
In a knowledge and financial economy characterized by combinatorial knowledge
dynamics (Crevoisier & Jeannerat, 2009), by project-based innovations (Grabher,
2002a) and by global financial and production networks (Coe et al., 2014), this idealized
approach of regional innovation and growth is called into question. Through outsourcing
and corporate venture strategies, multinational companies step in at an early stage of the
enterprises’ incubation (Chesbrough, 2002; Garel & Jumel, 2005; Ben Hadj Youssef,
2006). While local conditions of knowledge and capital transfers can be influential in
the emergence of entrepreneurship (Kenney & Von Burg, 1999; Delgado et al., 2010),
the growth of a start-up seems to be more than ever bound to the decisions of global sta-
keholders. What kinds of entrepreneurship, ecosystems and evolutionary paths are implied
by such interdependencies? How does it impact on theoretical and policy models of
regional innovation and territorial competitiveness?
Through the case study of Swiss medical technologies (medtech), this paper sheds light
on three different aspects of this question. Firstly, it is observed that medtech start-ups’
trajectories are shaped by the two contrasting territorial dynamics of knowledge and finan-
cial anchoring. While fundamental technology and incubation capital build on local
resources, industrial production and market exploitation take place, from its early phase
onwards, through the investments of large listed multinational companies. Secondly, the
entrepreneurial plan behind the creation of a new start-up indicates a fundamental
change is underway. While the economic potential of start-ups was traditionally viewed
as a longer term prospect, they are now “born to be sold”. Corporate venture has
become a strategic tool for large companies to tap external innovation processes taking
place in the local milieu. Thirdly, the identification and evaluation by investors of poten-
tially lucrative start-ups involve complex intermediation processes. From this point of
view, international fairs and opinion leaders are the key means of justifying and legitimat-
ing the value of local medtech start-ups, purchased as a product.
Regional Innovation: Localized Entrepreneurship and Industrial Growth
In a post-Fordist era, the term innovation is commonly used to explain the success of par-
ticular enterprises, industries and regions facing production cost competition in the globa-
lized economy. Inspired by Schumpeter’s approach to economic change, many
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contemporary theories and policy discourses view innovation as a dialectical interplay of
“emergence” and “growth” (Cooke et al., 2011b).
On the one hand, economic change and evolution emerge from entrepreneurship
(Rocha, 2004). Entrepreneurship is considered the fundamental socio-economic driver
through which contingent resources (Bathelt & Glu¨ckler, 2005; Stam, 2010; Julien &
Marchesnay, 2011) are turned into new products or production processes through creative
destruction, production and recombination (Schumpeter, 1935). Emergence occurs
through pioneer entrepreneurs or large incumbent firms breaking away from an existing
market offering (e.g. a new product or a new use of an existing product) and/or an estab-
lished production system (e.g. a new technology or a new supply chain).
On the other hand, growth in economic change is usually considered through the pattern
of industrialization (Klepper, 1997; Schmitz, 1999; Chataway & Wield, 2000). For
Schumpeter (1939, p. 98), innovations are not “isolated events”: they “tend to cluster,
to come about in bunches”. We here consider industrialization, in a broad and fundamental
definition, as the process by which related entrepreneurial projects and production are
developed on an extensive scale. Industrialization does not restrain to intensive manufac-
turing or economies of scale. It more broadly characterizes the agglomerated growth
(Hilhorst, 1998) achieved through “collective efficiency” and increasing returns derived
from external economies and joint action in particular production systems (Schmitz,
1999). It may be driven by processes of dissemination (e.g. through knowledge spillovers
or competition–cooperation dynamics), concentration (e.g. dedicated competences,
workforces and infrastructures) or specialization (e.g. a specialized supply chain).
Through productive, corporate or market growth, industrial development generates new
employment and new commercial revenues in relation to product and process innovations
(Klepper, 1997).
In regional studies, entrepreneurship is usually regarded as the capacity of local actors to
foresee and undertake individual and collective projects in a changing environment, based
on specific regional resources (e.g. social, cultural or technical capital) (Saxenian, 1994;
Maillat, 1995; Thierstein & Wilhelm, 2001; Stam, 2007). Innovation develops endogen-
ously within local production systems competing beyond regional boundaries (Coffey &
Pole`se, 1984). More operational approaches have subsequently viewed entrepreneurship
as the ability of specific regional innovation systems to turn locally generated knowledge
into successful entrepreneurial projects (Cooke, 2001; Doloreux, 2002) where entrepre-
neurs are considered not only as an individual pursuing a personal vision, but also as a
social agent situated in a wider system of production (Scott, 2006, p. 4). Within this
system, local venture capital investors are the key players providing capital resources
and managing expertise and strategic directions in the development of nascent firms
(Florida & Kenney, 1988; Kenney & Von Burg, 1999; Feldman, 2001).
In the past decades, the spatial dynamics of entrepreneurship and emerging innovations
have been the subject of various analyses particularly focused on regional economic
growth and clusters (Kenney & Von Burg, 1999; Feldman et al., 2005; Kiese &
Scha¨tzl, 2008; Glaeser & Kerr, 2009; Delgado et al., 2010; Trettin & Welter, 2011). In
this context, clusters and entrepreneurship have become very popular subjects in regional
science and economic geography (Sternberg & Litzenberger, 2004). According to Delgado
et al. (2010, p. 500) and Sternberg and Litzenberger (2004, p. 770), clusters facilitate new
business formation and the growth of successful start-ups by lowering the cost of entry,
enhancing opportunities for innovation-based entry, allowing start-ups to leverage local
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resources to expand new businesses more rapidly and offering a positive regional environ-
ment. Reducing barriers to entry and growth and enhancing regional comparative advan-
tage, the presence of a strong cluster environment should be a central factor of
entrepreneurial vitality (Delgado et al., 2010, p. 498). Not merely the result of individual
efforts, entrepreneurship has been depicted as a collective process embedded in particular
relational, institutional and evolutionary configurations situated in time and space
(Feldman, 2001; Lambooy, 2005; Ferrary, 2008). Stam (2007) emphasizes that new enter-
prises creation is characterized by different evolutionary phases beginning with recog-
nition of a new business opportunity by the entrepreneurs and ending in a “growth
syndrome” represented by a decrease of a firm.
Not confined to the question of entrepreneurship, industrialization has also been
addressed as a sine qua non condition of development within territorial innovation
(Scott, 1986; Scott & Storper, 1992; Hilhorst, 1998; Schmitz & Nadvi, 1999). Not only
have regional innovation systems been depicted as spatial contexts of emerging inno-
vation, but they are also particular socio-economic arenas enabling entrepreneurial pro-
jects to “take off” and, at the same time, “anchoring” them through local clusters of
activities (Porter, 1998; Cooke & Martin, 2006), enhancing knowledge dissemination,
flexible specialization (Scott, 1988; Simmie, 2005), related innovations (Frenken &
Boschma, 2007) or spatial agglomeration (Stam, 2007; Vatne, 2011). If regional clustering
of innovation does not necessarily follow the trajectory of a single industry, its endogenous
development bears an industrial dimension following the sequential homogenization
phases of activities in particular industrial or thematic fields (Menzel & Fornahl, 2010).
This industrial aspect of clustering has given rise to debated models of territorial com-
petitiveness, highlighting the regional advantage created by a “Marshalian” specialization
(Moulaert & Sekia, 2003) or by a “Jacobian” diversification of local innovative activities
(Cooke, 2008). Nevertheless, all these models share a common view: understanding terri-
torial competitiveness is not only about pointing out how innovation emerges in a particu-
lar spatial context, but also about addressing how innovation generates new employment
and revenue through export-based (basic) and induced (non-basic) activities in this terri-
tory (Pole`se & Shearmur, 2009).
The Life Cycle Approach: A General Conception of Regional Development
The interplay between entrepreneurship and industrialization in regional innovation pro-
cesses has traditionally been interpreted and conceptualized in a life cycle approach.
Initially adopted by Marshall (1890), who compared the evolution of businesses in the
nineteenth century with the birth, growth, maturity and death of trees in a forest, the
“life cycle” metaphor has gained common currency in describing the organic nature
of economic processes (Penrose, 1952). Used to describe the way in which firms and
industries develop within the ecological context of technology, product and market
selection, several approaches based on life cycle posit innovation as sequential waves
of emergence, growth, maturity and decline (Vernon, 1966; Markusen, 1985; Klepper,
1997). Drawing upon a similar metaphor, numerous works have provided various
interpretations of territorial competitiveness along with the different stages of develop-
ment that particular regional production systems may face (Vernon, 1966; Stam, 2007;
Menzel & Fornahl, 2010; Potter & Watts, 2011; Tichy, 2011; Cooke et al., 2011a;
Cooke et al., 2011b).
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In phases of emergence and growth, geographical proximity can provide relational
(e.g. informal, multifunctional or specialized networking among regional economic
and non-economic actors) and institutional facilities (e.g. routines and policy support)
to stimulate new entrepreneurial projects and to overcome market or technological
uncertainties related to the creation and industrialization of new market offerings
(Stam, 2007; Carrincazeaux & Coris, 2011; Potter & Watts, 2011). This phase is charac-
terized by two dominant processes related to the exploitation of new market opportu-
nities and the delivery of products to a growing product market (Stam, 2007, p. 30).
In the maturity phase, standardized technologies, production processes and markets
become less dependent on a particular innovation milieu. Relocation of activities is
easier and creates a new spatial division of labour in a global market (Vernon, 1966;
Tichy, 2011). Increasingly based on extra-regional relations or global pipelines
(Bathelt et al., 2004; Isaksen, 2011), the stages of maturity and decline are usually
not directly related to innovation-driven territorial competitiveness. Innovation may
develop incrementally alongside a particular market positioning and sectoral trajectory,
but competitiveness is primarily achieved through conservative principles (market oligo-
polies, technical and structural path dependencies) underlying a potential decline in the
original production system through latent lock-in (Grabher, 1993; Boschma &
Lambooy, 1999).
From this point of view, territorial innovation models have hitherto primarily focused
on regional emergence and growth of innovation (Asheim & Coenen, 2005; Cooke
et al., 2011a). Phases of maturity and decline are usually regarded as inevitable aspects
of new potential emergence through innovative diversification, adaptation or reconver-
sion. Regional innovation systems do not necessarily draw upon a single product or
sector. They usually build upon subsequent emergences and related industrial life cycle
types (Cooke et al., 2011b). In other words, regional innovation systems are fundamentally
depicted as specific territorial contexts of entrepreneurial (re)emergence(s) and industrial
growth through a local innovative valuation of resources (Figure 1).
Figure 1. Innovative emergence and growth in regional innovation systems.
Source: Author’s own work.
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Innovation Policies and Contemporary Reflections
In the last decade, a plethora of public initiatives has been launched to enhance regional
innovation and territorial competiveness. Usually taking the case of the Silicon Valley as a
reference, “technopole” and “cluster” strategies are considered as policy best practices
(Martin & Sunley, 2003; To¨dtling & Trippl, 2005; Brenner & Schlump, 2011). In
various aspects, these policies are implicitly rooted in a life cycle approach of regional
entrepreneurship and growth.
On the one hand, these policies seek to stimulate pioneer entrepreneurs and incumbent
companies by providing pre-competitive funding to R&D projects and start-up ventures.
On the other hand, they aim to foster creative knowledge sharing and dissemination
among regional actors in related fields of activities through proactive networking. Gener-
ally speaking, public intervention tends to be viewed ideally as the third component in a
triple-helix scenario, whereby it provides “assistance” for the emergence and growth of
“linear” innovations taking place between science and industry (Etzkowitz & Leydesdorff,
2000; Thierstein & Wilhelm, 2001; Etzkowitz, 2006).
Such initiatives tend to share an implicit view of innovation: successful start-ups are the
embodiment of innovation (Feldman, 2001) facilitating sometimes nascent industries that
will underlie the resilience and growth of a regional production system; supporting the
emergence of local innovation today prepares the ground for the industries of tomorrow;
new regional employments and revenues will come along with innovations. This stylized
approach to regional innovation and growth policies can nevertheless be challenged.
Drawing upon various seminal critiques addressed by recent debates in regional studies,
three prominent and fundamental issues emerge.
Firstly, in a complex knowledge-based society, economic development and competi-
tiveness are strongly driven by combinatorial knowledge dynamics (Gibbons et al.,
1994; Crevoisier & Jeannerat, 2009). Innovation increasingly tends to emerge across
different sectoral life cycles rather than within single trajectories. Accordingly, regional
innovation tends to emerge and develop through related varieties taking place across
different local clusters and life cycles (Asheim et al., 2011).
Secondly, in this context of knowledge-intensive innovation, entrepreneurship builds on
permanent and shorter-run projects (Grabher, 2002b). Regions are, in this context,
complex “project arenas” (Qvortrup, 2006) or “adaptive systems” (Martin & Sunley,
2011) of continuous innovative (re)emergence that have to overcome the path-dependent
lock-ins inherent in long industrial waves and stable phases of industrial maturity. Further-
more, regional revenue is generated from knowledge-intensive activities, selling tailor-
made solutions rather than export-based products.
Finally, territorial innovation processes are embedded in increasingly global production
and financialized networks (Corpataux et al., 2009; Coe et al., 2014). In the traditional life
cycle approach to territorial innovation, spatial division of labour was traditionally
described as a “push” movement (Tichy, 2011): the relocation of activities and foreign
direct investments are undertaken by mature companies from their home region towards
specialized and lower-cost supplying regions. Nowadays, this traditional process is chal-
lenged by two fundamental phenomena. On the one hand, global economic financializa-
tion has increased the liquidity/mobility of capital, which can be instantly invested in
distant and attractive listed businesses (Corpataux et al., 2009). On the other hand,
large multinational companies have become global investors in outsourced innovations
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through corporate venturing (Chesbrough, 2002; Garel & Jumel, 2005; Ben Hadj Youssef,
2006). In this context, relocations and foreign direct investments tend to occur at an earlier
development phase in a “pull” process, which consists of “picking up” the competitive
winners within global innovation networks.
How do these new challenges actually affect established models of regional innovation
and territorial competitiveness? How should conventional policy and life cycle approaches
be reconsidered in such a context? The next section examines these questions through the
particular case of medical technologies in Western Switzerland and tries to give new keys
to understanding the territorial and industrial dynamics of firm emergence and develop-
ment.
The Medtech Industry in Western Switzerland
The medical innovation literature shows that new medical devices and applications arise
out of interactions between different actors such as universities, hospitals, laboratories and
enterprises (Gelijns & Thier, 2002) and emphasizes that structures shaping innovations
can be distinguished from pharmaceuticals and biotechnology (Weigel, 2011, p. 45).
Considered to be the area of life sciences covering the various economic activities of
research, subcontracting, development and marketing of medical devices and applications
(Medtech Switzerland, 2012), medtech is one of the Swiss economy’s flagship industries,
generating around $5 billion per annum (Klo¨pper & Haisch, 2008, p. 11) and employing
some 50,000 people (i.e. 1.1% of the country’s workforce) (Medtech Switzerland, 2012,
p. 31). This sector shows a sustained annual growth of 5–20% depending on the industrial
branches (Fritschi, 2006).
The Swiss medical industry currently accounts for a total of 1600 companies1 subdi-
vided into manufacturers, producer suppliers, distributors and companies specializing in
the supply of services to medical device producers (Medtech Switzerland, 2012,
pp. 30–31). According to Klo¨pper and Haisch (2008), changes in the Swiss medical indus-
try have primarily been driven by three factors. Firstly, medtech companies have bene-
fitted from the Jura region’s rich technological and research environment, thanks to the
existing watchmaking industry there, producing various high-quality, high-precision com-
ponents. Secondly, the high prices on the Swiss domestic market have often meant that
there is money available for medical investment and innovation, helping local businesses
to be more innovative than their market competitors. Thirdly, research by public labora-
tories, both basic and applied, has enabled the development of major medical projects
within the country.
Territorially speaking, most businesses involved in medical work are based in the
Zu¨rich and Western Switzerland regions (Figure 2). With a long tradition in this field,
the latter region has a dense population of medical actors (e.g. state-run hospitals and
private clinics), research institutes (e.g. the university institute and private research invest-
ment), industry’s major multinational companies (Klo¨pper & Haisch, 2008, p. 12) and a
growing number of medtech start-ups (Figure 3).
Compared to the rich literature on innovations and clustering evolution in biotechnol-
ogy, the existing literature on medical device industry is very limited (Weigel, 2011).
This lack of literature raises some important issues for terminology and definition of
“medtech”. While the term “medtech” is commonly used by both public authorities to
define a promising industry and entrepreneurs to designate their business activity, this
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term is inherently ambiguous. It can effectively be seen as both a service industry and a
goods industry, as it represents not only those industries which produce medical devices
but also those actors supplying services which are not identifiable with a specific
product or technology. Henceforth, despite being implied by the term, “medtech”
cannot be defined as a technology or by a clearly identifiable product type. For this
reason, numerous actors in this field prefer to view medtech activities not as a specific
technology or sector, but rather as a “market”.
Figure 2. Number and localization of Medtech manufacturers and suppliers in Switzerland.
Source: Medtech Switzerland, 2012, p. 31.
Figure 3. Medtech start-ups founded in Western Switzerland between 2001 and 2012.
Source: www.startup.ch, as per 12.12.2013.
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These considerations raise several questions: how do we define current medtech activi-
ties? Would it be appropriate to speak of the emergence of a new medical cluster in
Western Switzerland? How should we interpret and understand the emergence and devel-
opment of these activities through the medtech start-ups that have recently sprung up in
this region? What kind of critical reflections might the case of Western Switzerland’s
medtech industries bring to bear on the traditional cluster life cycle approach?
Method of Inquiry
These questions were examined in a case-study research (Merriam, 1998; Stake, 2005;
Gerring, 2007; Yin, 2009) carried out between October 2012 and March 2013 as part of
a project financed by the Fond National Suisse de Recherche Scientifique.2 According
to Merriam (1998), the case-study method provides insides into social phenomena in
order to demonstrate their complexity and the context within which they were drafted.
Therefore, it emerges from a process of interaction between information gathering,
interpretations, literature and reporting (Yin, 2009). Searching to analyse the industrial
evolution, socio-economic dynamics and territorial impacts of the medtech sector in
Western Switzerland, our qualitative study was principally based on a mix method mobi-
lizing semi-structured interviews, participant observation, panel of experts and an in-depth
document analysis.
Five categories of actors were particularly identified (Table 1). The first type was the
start-ups (a total of 16) developing new medical devices. According to Lebret (2007,
p. 24), we considered “start-ups” as nascent firms, born from an entrepreneur’s idea
linked, or not, to an institutional actor (e.g. a university or a firm incubator) and having
the possibility to become a larger enterprise. The second and the third types of actors
were multinational enterprises (MNEs) and medium-sized enterprises (a total of 15) pro-
ducing and selling medical devices in international markets. Fourthly, particular investors
(a total of 5) were also interviewed to address the financial issues and rationales underlying
the creation and the development of new firms. Finally, the fifth category is represented by
professional associations and exhibition organizers, which provide a network creation
between medical actors.
A total of 30 semi-directive interviews lasting one to two hours have been conducted in
the Western Switzerland region with entrepreneurs, and representatives of small and
medium enterprises (SMEs), of MNEs, of investors and of professional associations.
The interviewees were selected according to a theoretical sampling (Guillemette & Luck-
erhoff, 2009), seeking to explore the general characteristics of medtech entrepreneurs,
their networks, their enterprises and their regional involvement. The particular history
of the firms, of their products and of their funding was examined. An in-depth web and
document analysis was also realized to gather information about innovative projects,
initiatives and experts’ views related to medtech activities in Western Switzerland and
abroad.
Once a saturation of results was achieved,3 all interviews were transcribed and subjected
to qualitative data analysis4 (Corbin & Strauss, 2008; Silverman, 2010; Grbich, 2012). Our
qualitative data were analysed through a conceptual coding (Nagy Hesse-Biber & Leavy,
2011). A descriptive coding of the textual and contents data generated by interviews and
documents allowed us to build analytical categories to interpret three main issues: (1) the
main changes in the medtech sector over the last years in Western Switzerland, (2) the
9
reasons of the actual evolution of local medtech start-ups and (3) the socio-economic and
spatial relations of actors involved in this evolution (e.g. MNEs, investors and associ-
ations).
As our inquiry is based on qualitative methods, our aim was not to consider it as repre-
sentative, but to allow us to propose a description of a different logic characterizing the
Table 1. Field actors and their principal functionsa
Categories of
actors
Semi-structured
interviews and
document analysis
Document
analysis and
participant
observations Function of actors Examples
Start-ups Aleva
Neutherapeutics,
Sensimed, Melebi,
Medos, Odus
Technologies,
Perfusal and other
5 medtech start-
ups
5 local medtech
start-ups
Develop a new
application
trying to solve
some medical
problems
Development of a
new soft
medical device
able to treat
diabetes
diseases
MNEs Medtronic, Phonak
and other 3 MNEs
1 MNEs Develop and sell
products at a
global scale
Worldwide
production and
sale of medical
devices or
application
(e.g. hearing
aid)
SMEs Symbios, Valtronic,
BienAir, Oscimed
and other 3 SMEs
2 local SMEs Develop, produce
and sell
product at a
more regional/
multinational
scale
Development and
production of a
new sort of
prosthesis to
sell in the
region and in
some other
occidental
countries
Investors Capital proximite´,
and other 3
investors
1 investors Support start-ups
creation and
development in
order to have a
capital gain
Monetary support
during an early
stage of new
medtech firms
Associations
and
expositions
Medi SIAMS, and
other 2
associations/
expositions
NEODE, Forum
Medtech
Luzern,
LausanneTec,
SMT Gene`ve,
Platinn,
BioAlps
Support the
creation of
networks
between actors
and the
development
of a medical
market
Networking
support
between
medical local
actors
legitimizing
global and
technical
opinion
Source: Author’s own work.
aTo provide some degree of anonymity for the respondents, only the names of actors that agreed to be cited are
used in this paper.
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cluster. Following Flyvbjerg (2006), the main objective was not to generalize from our
case study on medical technologies but to propose a key to understand firm creation
from the actors’ perspective. In fact, this case-study research enabled us to better under-
stand the processes at play within local innovative businesses, to comprehend the way
in which these businesses have evolved, to uncover the relationships forged between
these businesses and the multinationals and to gain a better insight into the impact that
intermediary actors have on these processes.
From Regional Incubation to Multinational Buyout
While technical skills are straightforward enough to come by through local research insti-
tutes, in the case of medtech in Western Switzerland it is clear that start-ups struggle to find
the local financial backing required for their research and development needs. According
to Crevoisier (1997), new firms are often initially supported through local finance.
However, with copious red tape and high production costs, medtech start-ups are increas-
ingly dependent upon multi-local financing for their development. Innovative businesses’
development is, therefore, no longer solely linked to the region’s capacity to provide local
investment (bank loans, public authority support, etc.), but to their capacity to attract the
interest and support of the major groups organized at the global level. This model is over-
turning the way local innovation systems work, as most start-ups are generally founded by
entrepreneurs looking for the business to be sold on the market at a profit.
On the basis of our case study, we have identified three typical phases in the development
of a medtech start-up (Figure 4).
Characterized primarily by a general lack of their own resources and by a great deal of
uncertainty, the first phase of a medtech start-up’s life cycle is all about ideation. In an
uncertain environment, securing financial capital for innovation often becomes extremely
difficult and requires the mobilization of external resources using alternative network-
based strategies. In Western Switzerland, the creation of these specific start-ups and the
Figure 4. The three phases of Medtech start-up financing.
Source: Author’s own work.
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design of the first prototypes are modestly financed and supported by government subsi-
dies (Thierstein & Wilhelm, 2001) as well as through local capital (Crevoisier, 1997)
often obtained from the entrepreneurs’ own social network (e.g. family, friends and con-
tacts). Often the start-up process for innovative businesses involves the financial support of
private investors, primarily venture capitalists.
Rarely falling within the ambit of the entrepreneur’s social network, their financing of
development prototypes is done with a view to eventually making a profit. A great
example of this kind of local investment refers to a local start-up that created a special
glaucoma-detection contact lens. In fact, the statement of its entrepreneur exposes: “At
the beginning, we found our principal investments locally, thanks to friends and
family, especially for the creation of a prototype of our contact lens.”5 This statement
illustrates that the financial resources necessary to develop the first product prototype
came principally through the business owner’s own social network and certain public
financing initiatives aimed at the incubation and start-up of so-called pre-competitive
projects.
The second phase of the start-up’s life cycle covers the transition from prototype to
industrial production. In contrast to the start-up’s initial phase, the phase covering the tran-
sition from prototyping to industrial production of products requires much greater sums of
money, which are harder to source locally from small or medium-sized investors. The pro-
duction costs and the cost of the various requisite medical device certifications often
necessitate considerable investments, that is, in the region of 20–30 million Swiss
Francs.6 Only multinationals are able to provide this kind of liquidity for producing and
certifying new devices. These investments are very often based on corporate venture
capital (Chesbrough, 2002; Garel & Jumel, 2005), whereby multinationals take a share-
holding in promising companies (Ben Hadj Youssef, 2006). The diabetes treatment
device made by a local start-up is a good case in point as the statement of a chief devel-
opment officer confirms: “The certification process and first phase of industrial production
were supported by an American multinational based in the region which now plays a
decision-making role in our firm.”
The third phase primarily involves the market launch of the medical device and the
buyout of the start-up by a multinational. According to Narula and Santangelo’s thesis
(2009), medical multinationals based in the region achieve innovation not only through
the skills within their organization but also through outsourcing and the skills of their
external partners, be they research laboratories or businesses. They maintain ongoing
relationships, both financial and technological, with local entrepreneurial networks and
start-ups in order to benefit from their output and with a view to possibly buying out
the start-up, internalizing its product, its production and its specialist workforce. For
example, a young business based in Western Switzerland, specializing in the develop-
ment, production and marketing of implantable medical devices and accessories, was
bought out by a big American group in 1994 and was incorporated as a new business
within the family of this large group. The statement of a collaborator of this medical
company exemplified this issue: “It was 1994, a big American Group, focused on the pro-
duction of a similar product as ours, showed an interest for our company and we finally
decided to sell it them.” Similarly, the sale of medtech start-ups to quoted groups may
also depend on the entrepreneur’s willingness, as illustrated by the statement of a local
entrepreneur:
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When I established my new enterprise and started conceptualizing a prototype of the product,
I was sure that I would sell my start-up to a big group in the near future in order to have enough
money to then start a new business.
Looking at these three stages of evolution, we note two main issues. Firstly, start-ups
develop through both public and private local capital based on a relationship of trust
between actors (Crevoisier, 1997). Unlike the Silicon Valley ideal-type (based on an
influx of venture capital enabling the rapid creation of start-ups) (Comtesse, 2013,
p. 14), venture capitalists play only a minor role in the setting up of new medical
businesses in Western Switzerland. According to the Garel and Jumel approach (2005),
despite their minimal involvement in the creation of medtech start-ups, more substantial
investments come in the form of corporate venture capital bestowed by large stock-
market-listed companies. Although these investments support start-ups through the
process of certification and the initial manufacturing of products, they also enable the mul-
tinational to gain easy access to new technologies, to improve internal research and devel-
opment through the applications developed by the start-up, to identify new markets and,
indeed, to create a profit (Chesbrough, 2002; Ben Hadj Youssef, 2006).
Secondly, these processes indicate a radical change to the industry’s traditional pro-
cesses of innovation and development. The typical view of the innovative entrepreneur
is that of a person setting up a business with the aim of creating endogenous growth
through the sale of his or her product (Lebret, 2007). The product is the item to be com-
moditized and the start-up is the means by which it is invented and put on the market.
Therefore, the case of the medical industry in Western Switzerland evidences not only
the buyout of start-ups by multinationals but also a desire on the part of entrepreneurs
to create a business with the aim of selling it on to a large group within the short to
medium term. Although the buyout of start-ups by listed companies is hardly unusual,
the commonly expressed desire of entrepreneurs to sell on their business is a more
recent phenomenon. In such cases, the medical product becomes more a means of increas-
ing a company’s value in the start-up market. The proliferation over the last 10 years of
prizes and quality kitemarks being awarded to start-ups rather than to specific products
is a good illustration of this turnaround. For example, a local start-up received in 2013
a prize from public authorities considering it as the third best innovative start-up in Swit-
zerland. According to its entrepreneur, this prize “allowed the start-up to find more easily
new investors for the creation of the firm and new buyers”.
The Construction of the Medtech Start-up Market
Traditionally, start-ups are actors dedicated to creating new products for exploitation on
the market which should enable them to develop into SMEs (Lebret, 2007). Our case
study shows that start-ups do not concentrate solely on the creation of medical devices
to be sold on the market. They also increase their intrinsic market value, thanks to the
support of intermediary actors (e.g. opinion leaders) and the development of profitable
products. On the one hand, this increase in value enables private investors (and particularly
the initial venture capitalists) to make a profit at the first stage of the products’ sale and at
the final stage of the start-up’s sale to the large stock-market-listed groups. On the other
hand, this increase in value enables the entrepreneur to make more money, thanks to
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the buyout of the start-up by a multinational, which often already has a stake in the
company through corporate venture terms (Garel & Jumel, 2005).
Generally speaking, medtech start-ups are being less and less viewed as nascent pro-
ductive companies and more and more as socio-technical devices designed to be marketed.
In other words, the medical product developed by a start-up becomes just one of various
identifying features of a marketing concept which is sold in the form of a complex entre-
preneurial project.
In a process of perpetual reinvestment, money made on the sale of the start-up is often
reinjected into the system by the entrepreneur to set up a new one. Developed through a
regional business incubator, a local start-up is involved in the development of neurostimu-
lation technologies enabling improved therapies for neurological diseases. This start-up is
a good example of the described phenomenon, as the statement of the main contractor con-
firms: “During the creation phase of my start-ups, my objective was clearly defined;
I wanted to create a new medical application and a new enterprise potentially attractive
for investors and specific multinational enterprises interested in a firm purchase.” This
innovative business was recently bought out by an American multinational, wanting to
apply the concept developed by the start-up to its own products. Consequently, the
medical device is no longer just considered a panacea through which to develop the
business and to expand to become leaders within their sector; rather, the product is seen
as the medium through which the business’s image is to be promulgated, to attract inves-
tors and ultimately sell the start-up.
In our particular case, the construction of the medtech start-up market in Western Swit-
zerland occurs through the intermediation of “legitimating third parties” whose power is
enacted in specific events and forums. While an entrepreneur’s network of contacts and
their friends and family may provide the necessary cognitive and financial resources to
get a start-up going (Crevoisier, 1997; Grossetti, 2006), intermediary actors help boost
the value and legitimacy of an innovative business in the eyes of investors and market
product distributors. When seeking financing, a market for their products and the requisite
certification for their devices, entrepreneurs call upon opinion leaders, key figures in the
medtech sector. Crucial players in the dissemination of new products (Van Eck et al.,
2011), they are capable of influencing the opinions, attitudes, motivations and behaviour
of others, and define themselves as “people in a social network who, in the diffusion of
product and technologies, have greatest influence on their acknowledgment or adoption
by other people” (Cho et al., 2012, p. 97). Largely made up of specialist doctors within
the medical field of the product in question, opinion leaders provide legitimacy and credi-
bility for both the start-up and the medical device, firstly in the eyes of investors and sec-
ondly, of distributors and their customers (Figure 5). Without this specific support,
entrepreneurs would be hard-pressed to mobilize the capital required to develop their pro-
ducts or to raise the interest of investors and distributors in their medical applications.
In opposition to Florida and Kenney’s arguments (1988), investors’ evaluations of start-
ups and their products are not based purely on the criteria of originality, patents or the pres-
ence of competitive businesses on the market. On the other hand, investors’ valuations are
based primarily on quality considerations (in relation to ratings agency certifications) as
well as the credibility afforded them by opinion leaders and a product’s potential range
of applications. Similarly, the legitimization of these products by opinion leaders occurs
in specific locations, notably business platforms (Cooke et al., 2011; Gawer, 2011), rep-
resented by trade fairs, specialist shows or medical conferences. These privileged
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meeting places shape relations between actors by, on the one hand, enabling entrepreneurs
to present their own business to specialists within the field, and, on the other hand, confer-
ring both technical and symbolic value upon the products through the support of opinion
leaders.
Discussion: Re-conceptualizing Start-ups in Regional Innovation
Based on the case of the medical industry in Western Switzerland, and more specifically
start-ups in the region, we have discerned three key issues (Table 2): (1) the development
trajectory of start-ups and the resources mobilized, (2) the modalities of their market
evaluation and valorization and (3) the spatial organization underlying their evolution.
Firstly, medtech start-ups are primarily born of entrepreneurial instinct, which follows
on from an entrepreneur’s higher education. Unlike the traditional creation of innovative
companies by the “intrapreneuriat” (Hulsink & Manuel, 2006; Hatchuel et al., 2009), the
creation of innovative medtech businesses is less dependent on the entrepreneur’s having
prior experience in a relevant business. In fact, it is often the result of an individual
attempting to respond to real-life problems that he or she has encountered, and the
desire to ultimately make a profit when it is sold to a large group. In this situation, the
requisite technologies are often to be found in the region, thanks to its numerous research
laboratories. By analogy with Crevoisier (1997), when creating start-ups, entrepreneurs
primarily rely upon their own personal network of contacts for financial resources.
However, in the product certification and manufacturing phase, it is corporate venture
capital (Garel & Jumel, 2005) which is most often relied upon.
Figure 5. Medtech start-ups in the local environment and the role of legitimating third parties.
Source: Author’s own work.
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Secondly, the territorial aspects of the innovation processes studied and the medtech
start-ups in Western Switzerland indicate that medical devices are now created and devel-
oped using resources from both local sources (local capital and technologies) and multi-
local sources (venture capital and corporate venture capital). Interactions between regional
actors are based on local relationships of trust, similar to those described in the approaches
to territorial innovation models (Moulaert & Sekia, 2003). These actors develop networks
which enable them to combine regional competencies and to create productive synergies
(Scott, 2006). However, innovative businesses are increasingly part of networks which
transcend regional boundaries. Medtech start-ups both need and benefit from multi-local
networks in order to attract the requisite financial resources to develop their products
and to interact with key market players such as distributors and opinion leaders. Thus,
the local anchoring and subsequent development of the innovative business are quite
weak following the start-up’s acquisition by a multinational, which often relocates it
outside of the region.
Thirdly, the ultimate aim of medtech start-ups and those who start them is no longer to
develop a new business producing medical devices over the long term, but rather to create
a socio-technical concept to sell on to a large group in the medical industry within the short
to medium term. For innovative businesses to attract the attention of these large groups,
start-ups require the support of key intermediary figures: opinion leaders. As highlighted
by Van Eck et al. (2011), these actors confer legitimacy upon and create confidence around
start-ups and their products, enabling them to attract the necessary resources to set up a
business and create products. In this particular situation, the start-up’s value is based
Table 2. Two contrasted start-up approaches
Start-up as nascent
enterprise/industry Start-up as products
Entrepreneurship/
emergence
Entrepreneurial project of a
productive business
Market solution and entrepreneurial
concept incubated after leaving
higher education.
Technology To develop and exploit
within production
Made available as a concrete
prototype and entrepreneurial
concept
Product Market commodity Socio-technical component of an
entrepreneurial concept
Objective of
entrepreneur
Development of a new
product (exploitation over
the long term)
Selling the start-up to a MNE during
the emergence phase (added value
on equity)
Investments Proximity capital and
traditional bank loans
Public and private proximity capital
and corporate venture investments
Start-up evaluation In the product market Legitimacy of the entrepreneurial
concept by intermediaries
(credibility, trust of opinion
leaders, etc.) and financing actors
Territoriality of relations
(temporal evolution)
1 Local Local and multi-local
2 Supplements coming from
elsewhere
Multi-local (selective anchoring)
Source: Author’s own work.
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not only on technical factors but also on the legitimacy and symbolic value conferred upon
it by intermediary actors.
Conclusion: What Life Cycle Approach to Territorial Competitiveness?
Characterized by much diversified firms, technologies and products, medtech activities in
Western Switzerland are primary related through their common market orientation. Highly
regulated by international technical and safety norms and organized around large strategic
players (e.g. hospitals or large medical equipment suppliers), entering such a market is par-
ticularly difficult for new comers. Building up their own production tools and distribution
channels often requires unaffordable investments for start-ups.
In this context, strategic partnerships or mergers with established multinational compa-
nies are usually seen as the most pragmatic—if not the only—way to pursue their indus-
trial development. Consequently, start-ups tend to be conceived from their creation as
products commoditized and qualified by various socio-technical devices in market (e.g.
certificates, awards or opinion leaders). If such a phenomenon is particularly enhanced
in the context of medtech activities, more general considerations and concerns for territor-
ial innovation can be drawn out of this specific case.
If the dual dimension of start-ups, either as “nascent enterprise/industry” or as
“product”, has always been recognized (Kenny & Von Burg, 1999), territorial innovation
models and policy (best) practices traditionally tend to associate their emergence and
growth with the development of local industries, either as industrial pioneers or as inno-
vative spin-offs embedded in a regional production system. This vision reflects a spatial
division of labour “pushed” by innovators and investors originating from developed
countries. This also postulates a limited mobility of production factors (e.g. firms, technol-
ogies and workers) in the industrial growing phase of regional innovation.
Adopting such a traditional approach leads to interpreting the case of medtech activities
in Western Switzerland as the emergence of a new cluster meant to develop and create new
competitive enterprises and industrial boundaries, to provide new regional growth of
revenue and employment in the region. In other words and by analogy to the canonical
model, this could be viewed as the emergence of a Swiss “Medtech Valley”.
However, such an interpretation could fall short of a pertinent analysis when consider-
ing future challenges for regional medtech activities. A greater emphasis on start-ups as
“products” raises new avenues for research and policy approaches to territorial innovation
and competitiveness. Three fundamental open questions seem to us crucial to be asked in
this regard (Figure 6).
Firstly, “will regional innovation systems be confined to short-run project life cycles of
emergence and reemergence?” In the medtech case examined in the article, entrepreneur-
ial projects seem to consist more and more in combining existing knowledge (science,
technology and culture based) in a business idea and advertising it through a start-up
concept meant to generate itself a profit. Such projects mirror a knowledge-based
economy marked by permanent innovation where the constant renewal of entrepreneurial
projects becomes the key factor of competitiveness. In this view, more stable phases of
industrialization tend to be shaded by perpetual sequences of emergence and reemergence.
Beyond a life cycle approach, future research avenues and policy issues will have to be
able to identify the industrial dynamics of growth induced, or not, by this “project
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ecology” (Grabher, 2002b) and to understand how they contribute, or not, to broader
regional innovation systems.
Pursuing a same line of reflection, a second provocative question arises: “will commo-
ditized entrepreneurial projects become the new revenue model of lead innovative
regions?” Regional competitiveness is usually conceived as the capacity to produce inno-
vative goods or activities and to export them. Sold as products, entrepreneurial projects
become themselves commoditized revenues for innovative regions. Within global pro-
duction and financial networks, innovators and investors are, nowadays, not only situated
in the traditionally called “developed countries”. Highly mobile, knowledge and financial
resources circulate and anchors across territories, pulled by foreign direct investments
chasing most attractive innovations and entrepreneurial projects. Purchased in the early
phase of emergence, innovations can be more easily relocated according to the corporate
strategies of multinational companies. Depicting today’s territorial revenue models should
be at the core of future research and policies agenda to understand how regional wealth is
actually generated. Traditional export-base models of growth will certainly have reconsid-
ered in such enterprise.
Finally, these two fundamental questions underlie the general exploratory question:
“how current regional innovation systems will be able to position themselves within
global networks to attract and anchor knowledge and financial resources?” As pointed
out by the case of Swiss medtech start-ups, being competitive today is not only being inno-
vative. Policies of knowledge creation and transfer are for sure influent factors of regional
innovation. However, as illustrated earlier, local innovation is also about being able to
advertise local entrepreneurship to global players and investors. It is also about thinking
how such projects and the revenue they generate will stimulate the renewal of future pro-
jects as well as develop within broader industrial growth.
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